应用改良Bu/Cy/Mel预处理方案的单倍体移植提高单中心68例难治复发急性髓系白血病的临床疗效(3)
參考文献
[1] Rowe JM， Tallman MS. How I treat acute myeloid leukemia. Blood， 2010， 116(17)：3147-3156.
[2] D?hner H， Estey EH， Amadori S， et al. Diagnosis and management of acute myeloid leukemia in adults： recommendations from an international expert panel， on behalf of the European LeukemiaNet. Blood， 2010， 115(3)：453-474.
[3] Ravandi F， Ritchie EK， Sayar H， et al. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR)： a randomised， controlled， double-blind， multinational， phase 3 study. Lancet Oncol， 2015， 16(9)：1025-1036.
[4] Lamba JK， Chauhan L， Shin M， et al. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia： Report From Randomized Phase ⅢChildren’s Oncology Group Trial AAML0531. J Clin Oncol， 2017， 35(23)：2674-2682.
[5] Tasian SK. Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy： how far up the road have we traveled？ Ther Adv Hematol， 2018， 9(6)：135-148.
[收稿日期：2020-05-11], 百拇医药(魏志杰)
[1] Rowe JM， Tallman MS. How I treat acute myeloid leukemia. Blood， 2010， 116(17)：3147-3156.
[2] D?hner H， Estey EH， Amadori S， et al. Diagnosis and management of acute myeloid leukemia in adults： recommendations from an international expert panel， on behalf of the European LeukemiaNet. Blood， 2010， 115(3)：453-474.
[3] Ravandi F， Ritchie EK， Sayar H， et al. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR)： a randomised， controlled， double-blind， multinational， phase 3 study. Lancet Oncol， 2015， 16(9)：1025-1036.
[4] Lamba JK， Chauhan L， Shin M， et al. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia： Report From Randomized Phase ⅢChildren’s Oncology Group Trial AAML0531. J Clin Oncol， 2017， 35(23)：2674-2682.
[5] Tasian SK. Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy： how far up the road have we traveled？ Ther Adv Hematol， 2018， 9(6)：135-148.
[收稿日期：2020-05-11], 百拇医药(魏志杰)